Nucleus working to expand development, supply, and commercial manufacturing capabilities to make targeted radiotherapies and theranostics more accessible.
Enables Bristol Myers Squibb to expand its manufacturing capacity, meeting the growing demand for its range of cell therapies through Cellares’ platform.